市场调查报告书
商品编码
1433457
2023-2030年全球下肢义肢市场Global Lower Limb Prosthetics Market 2023-2030 |
预计在预测期(2023-2030年),全球下肢义肢市场将以5.2%的CAGR成长。推动下肢义肢市场的重要因素包括健全的医疗基础设施、增加下肢义肢研发投资以及不断增加的创伤和事故病例。道路事故会导致各种骨头骨折,包括四肢的骨折,例如腿、膝盖和脚。根据英国政府提供的国家统计数据,2022年,共有29,742人死亡或重伤(KSI),登记死亡病例1,711例,各类严重伤亡人数135,480人。因此,英国的外科手术数量正在增加。
全球下肢义肢市场按技术、类型和最终用途进行细分。根据技术,市场分为电动下肢义肢、传统下肢义肢和混合式下肢义肢。根据类型,市场分为义肢腿、义肢足、义肢膝、义肢髋和义肢踝。此外,根据最终用途,市场细分为医院、诊所等。其他包括研究所。在最终用途中,由于可负担性、可近性和功能的改善,预计医院细分市场将占据相当大的市场份额。
在这些类型中,义肢髋关节细分市场预计将在预测期内成长。此细分市场的推动因素是人口中关节炎的盛行率不断上升以及假体髋关节手术的技术进步。根据美国疾病管制与预防中心的数据,2019 年至 2021 年期间,约五分之一的美国成年人(21.2%)或约 5,320 万人患有医生诊断的关节炎。与男性 (16.3%) 相比,女性 (20.9%) 更容易患关节炎。因此,关节炎发病率的增加预计将推动对义肢髋关节的需求。
全球下肢义肢市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本、韩国、亚洲其他地区)以及世界其他地区(中东和非洲、拉丁美洲。其中,北美在全球市场中占有相当大的份额。下肢义肢的需求不断增长,老年人口和不断增加的医疗保健支出对区域市场做出了贡献。
在所有地区中,亚太地区预计在预测期内将以显着的CAGR成长。在人口成长、人口老化和严重伤害数量不断增加等因素的推动下,亚太地区糖尿病等慢性病的盛行率正在上升。中国在亚太下肢义肢市场占据主导地位,其次是印度、日本、韩国和其他亚太经济体。由于下肢义肢的使用不断增加以及糖尿病等慢性疾病的盛行率不断上升,中国的下肢义肢市场正在经历成长。根据世界卫生组织的数据,中国是全球糖尿病患者数量最多的国家,2019年有近1.16亿活跃病例,预计到2040年将增加到1.5亿。预计2009年中国糖尿病盛行率为3.9%,预计到2030 年将增至5.4%。2020-2030 年中国20-79 岁成年人糖尿病盛行率预计将从8.2% 增至9.7%。
服务下肢义肢市场的主要公司包括 Blatchford Inc.、Bauerfeind AG、Otto Bock HealthCare LP、WillowWood Global LLC. 等。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2021 年 3 月,Boston Orthotics & Prosthetics 与俄亥俄州中部矫形与义肢中心 (COOP) 合作,为俄亥俄州中部的患者和家庭(包括全国儿童医院的患者和家庭)提供儿科矫形器和义肢服务。
Global Limb Lower Prosthetics Market Size, Share & Trends Analysis Report by Technology (Electric Powered Lower Extremity Prosthetics, Conventional Lower Extremity Prosthetics, and Hybrid Lower Extremity Prosthetics), by Type (Prosthetics Leg, Prosthetics Foot, Prosthetics Knee, Prosthetics Hip, and Prosthetics Ankle), by End-Use (Hospitals, Clinics, and Others), Forecast Period (2023-2030)
The global lower limb prosthetics market is anticipated to grow at a CAGR of 5.2% during the forecast period (2023-2030). Significant factors contributing to the limb lower prosthetics market include robust healthcare infrastructure, increasing investment in R&D of the limb lower prosthetics, and increasing number of trauma and accident cases. Road accidents lead to fractures of various bones, including those in the extremities such as the legs, knee, and foot. According to the national statistics provided by the UK government, in 2022, 29,742 people were killed or seriously injured (KSI) casualties, 1,711 fatalities cases were registered and 135,480 were casualties of all severities. As a result, the number of surgical procedures is increasing in the UK.
The global lower limb prosthetics market is segmented on the by technology, type, and end-use. Based on the technology, the market is sub-segmented into electric powered lower extremity prosthetics, conventional lower extremity prosthetics, and hybrid lower extremity prosthetics. Based on the type, the market is sub-segmented into prosthetics leg, prosthetics foot, prosthetics knee, prosthetics hip, and prosthetics ankle. Further, based on the end-use, the market is sub-segmented into hospitals, clinics, and others. Others includes Research Institute. Among the end-use, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the affordability, accessibility, and improved function.
Among the types, prosthetics hip sub-segments expected to grow over the forecast period. The segment is driven by the increasing prevalence of arthritis among the population and technological advancements in prosthetic hip surgeries. According to the Centers for Disease Control and Prevention, during 2019-2021, about 1 in 5 US adults (21.2%) or about 53.2 million people had doctor-diagnosed arthritis. Arthritis was more common among women (20.9%) compared to men (16.3%). Thus, the increasing incidence of arthritis is expected to drive the demand for prosthetics hip.
The global lower limb prosthetics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America held considerable share in the global market. The growing demand for lower limb prosthetics, increasing geriatric population, and rising healthcare expenditure contributing to the regional market.
Among all regions, the Asia-Pacific region is anticipated to grow at a significant CAGR over the forecast period. The Asia-Pacific region is experiencing a rise in the prevalence of chronic diseases such as diabetes, driven by factors such as population growth, aging demographics, and the growing numbers of severe injuries. China dominates the Asia-Pacific lower limb prosthetics market followed by India, Japan, South Korea, and the rest of the Asia-Pacific economies. The lower limb prosthetics market in China is experiencing growth owing to the increasing adoption of lower limb prosthetics and increasing prevalence of chronic disorders, such as diabetes. According to the World Health Organization, China has the highest number of diabetic patients globally, with nearly 116 million active cases in 2019, and is expected to increase to 150 million by 2040. The estimated diabetes prevalence rate in China in 2009 was 3.9% and is projected to increase to 5.4% by 2030. The prevalence of diabetes in Chinese adults aged 20-79 years is projected to increase from 8.2% to 9.7% during 2020-2030.
The major companies serving the lower limb prosthetics market include Blatchford Inc., Bauerfeind AG, Otto Bock HealthCare LP, WillowWood Global LLC., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2021, Boston Orthotics & Prosthetics partnered with the Central Ohio Orthotic & Prosthetic Center (COOP) to provide pediatric orthotic and prosthetic services for patients and families in Central Ohio, including those of Nationwide Children's Hospital.